GlassScriptPhysician profile
Elizabeth Bryson
NPI 1255364121
$2,795.89
in general payments reported to CMS, 2019-2025
22 companies · $358 in 2025
The $358 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,745 · 2022: $174 · 2023: $224 · 2024: $296 · 2025: $358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $778 · Education: $99.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $778.25 |
| Education | $99.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $1,562.50 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $175.75 | 2021-2025 | Trikafta |
| Mylan Specialty L.P. | $143.78 | 2022-2024 | Tobi Podhaler |
| Astrazeneca Pharmaceuticals LP | $138.72 | 2024-2025 | Fasenra |
| Amgen INC. | $115.74 | 2022-2025 | Tezspire |
| Genzyme Corporation | $102.05 | 2021-2024 | |
| Regeneron Healthcare Solutions, INC. | $99.22 | 2025 | Dupixent |
| Abbvie INC. | $77.38 | 2021-2025 | |
| Jazz Pharmaceuticals INC. | $65.99 | 2023-2024 | |
| Baxter Healthcare | $62.15 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Teva Pharmaceuticals USA, INC. | $55.45 | 2021 | |
| Nestle Healthcare Nutrition INC. | $34.31 | 2021-2023 | |
| Phadia US INC. | $22.85 | 2024 | Immunocap |
| Philips North America LLC | $18.82 | 2024 | (Ak6) Vest Therapy |
| Glaxosmithkline, LLC. | $17.94 | 2025 | Nucala |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $17.48 | 2022 | |
| Digestive Care, INC. | $16.86 | 2025 | Pertzye |
| Azurity Pharmaceuticals, INC. | $14.79 | 2025 | Alvesco |
| Sobi, INC | $14.41 | 2023 | |
| Pari Respiratory Equipment, INC. | $14.36 | 2021 | |
| Viatris Specialty LLC | $13.68 | 2025 | Tobi Podhaler |
| Genentech USA, INC. | $11.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Bryson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.